Your cells use the RPS26 gene to help build ribosomes, the tiny structures that make proteins. This gene plays an important role in steady growth and blood cell production, so if it does not work properly, some cells cannot make proteins well enough. Pathogenic variants in the RPS26 gene can cause Diamond-Blackfan anemia, which often leads to low red blood cells. You might notice tiredness or pale skin, and some people also have growth or physical differences present from birth.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Others mainly help control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
RPS26Gene function
What if the gene works
The RPS26 gene helps make part of the ribosome, the structure cells use to build proteins. This supports normal growth and the healthy development of blood cells.
Risk
What if the gene does not work
Variants in the RPS26 gene can cause Diamond-Blackfan anemia, with low red blood cell production leading to anemia, tiredness, and poor growth. Milder to more severe variants may influence how early features appear and whether physical differences are also present.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the RPS26 gene is currently established. Care is based on your clinical picture, using standard treatment for Diamond-Blackfan anemia or related bone marrow failure, while the RPS26 gene remains under study in ribosome biology research.
Conditions associated with RPS26
Gene function
What if the gene works
Your cells need the RPS26 gene for the steady work of making proteins. Its protein is part of the small half of the ribosome, the cell’s protein making machinery, and helps that machinery read genetic messages accurately. This supports everyday cell growth, repair, and routine maintenance.
The RPS26 gene helps ribosomes turn RNA messages into proteins. This lets cells build the enzymes, signals, and structural parts they need for daily function.
Its protein becomes part of the small ribosome subunit, which is one half of the cell’s protein-making machinery. This supports the normal assembly and stability of ribosomes so protein production can run smoothly.
RPS26 helps the ribosome recognize the right starting point on many RNA messages. This makes protein production more accurate and supports how the RPS26 gene helps make proteins in cells.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RPS26 gene can lower the amount of RPS26 protein made, make it unstable, or stop it from joining the cell's protein-making machinery, called the ribosome. In plain terms, how RPS26 gene variants affect protein production depends on the change: milder variants may partly reduce this process, while more severe variants can disrupt it more strongly. This difference may help explain why Diamond-Blackfan anemia can appear earlier or be more marked in some people.
How variants are linked to conditions
Pathogenic variants in the RPS26 gene are a well-established cause of Diamond-Blackfan anemia, often called DBA, a rare inherited condition marked by low red blood cell levels. In people with RPS26 gene variants and Diamond-Blackfan anemia, genetic results can confirm the diagnosis. This is the main condition consistently linked to this gene in human genetics studies.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the RPS26 gene. For many living with a harmful RPS26 change, the chance of related health problems depends mainly on the variant itself rather than lifestyle or everyday exposures. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of RPS26 variants
For families trying to understand how RPS26 gene variants are inherited, the best-established pattern is autosomal dominant. This means a parent carrying a disease-causing variant in the RPS26 gene can pass it to a child with a 50% chance in each pregnancy. Some people with an RPS26-related condition have a new, de novo variant, which means it was not inherited from either parent. The RPS26 gene is on chromosome 12, so this pattern affects males and females similarly.
What does my RPS26 result mean for my family?
A harmful change in the RPS26 gene is linked to a form of Diamond-Blackfan anemia that usually follows a dominant family pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, each child of someone with the variant has a 1 in 2 chance of inheriting it. Some cases happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the RPS26 gene, doctors use genetic testing, usually on a blood sample or cheek swab. Genetic testing for RPS26 variants reads the DNA code to check for changes that may help explain symptoms or confirm a suspected inherited condition. Results are interpreted alongside your medical and family history.
When should I consider getting a genetic test?
Genetic testing for the RPS26 gene may be considered if someone has signs of Diamond-Blackfan anemia, such as severe anemia starting in infancy, poor growth, or certain birth differences. It can also help when this condition runs in the family or when a child has unexplained trouble making red blood cells.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the intended benefit while another may notice less effect or be more sensitive to side effects. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape a person’s response to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how the body processes a drug and how strong its effects are. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the RPS26 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so concerns about side effects, trouble tolerating a medicine, or questions about how treatments may affect you are best discussed with your doctor.
History
First described in the scientific literature as part of studies on ribosomal proteins, the RPS26 gene drew wider medical interest when researchers linked variants in it to Diamond-Blackfan anemia, a rare inherited condition that affects red blood cell production. That finding, reported in the late 2000s, helped shift thinking about this condition by showing that changes in several ribosomal protein genes could be involved. From these first observations, research expanded steadily, and the RPS26 gene became part of a broader story about inherited bone marrow conditions. Over time, descriptions became more precise as genetic testing made it easier to identify people carrying RPS26 variants. These historical steps shaped today’s understanding of RPS26 as one of the genes clinicians may consider in inherited anemia.